TORVANTA
Compare · research updated Oct 20, 2026

HRMY vs SRPT: Harmony Biosciences Holdings, Inc. vs Sarepta Therapeutics

Harmony Biosciences Holdings, Inc. (HRMY) and Sarepta Therapeutics (SRPT) on Torvanta's measures: HRMY grades higher on 4 of the 4 factor families and SRPT on 0.

HRMYSRPT
Value gradeA-n/a
Growth gradeB-n/a
Profitability gradeA-D
Momentum gradeBC
Market value$2.3B$2.0B
P/E (trailing)12.5xn/a
Forward P/E (Torvanta model estimate)SubscribersSubscribers
Revenue, last 12 months$1.0B$2.0B
Revenue growth (y/y)+24%-20%
Operating margin24.0%-7.3%
Return on invested capital28.7%-6.3%
Free-cash-flow yield15.8%4.0%
Total return, 1 year+48.7%-16.8%
Total return, 3 yearsn/an/a

Full HRMY analysis · Full SRPT analysis

Frequently asked questions

Which is better, HRMY or SRPT?

Harmony Biosciences Holdings, Inc. (HRMY) and Sarepta Therapeutics (SRPT) on Torvanta's measures: HRMY grades higher on 4 of the 4 factor families and SRPT on 0. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.

Which is cheaper, HRMY or SRPT?

On trailing earnings HRMY trades at 12.5x and SRPT at n/a; their value grades are A- and n/a against their sectors.

See the Stock Analyst's view

Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer

Data powered by Tiingo.com